Abstract
Introduction: Chronic mucocutaneous candidiasis associated with autoimmunity and ectodermal dysplasia is an inborn error of immunity, characterized by a classic triad (chronic mucocutaneous candidiasis, hyperparathyroidism, and adrenal insufficiency) due to the presence of autoantibodies against different endocrine and non-endocrine organs; and it is predominant in Jews and Finns.
Case report: A 7-year-old girl of European descent and positive consanguinity, with a personal history of recurrent respiratory infections, chronic candidiasis, pseudomembranous colitis, and pancytopenia. The clinical findings raised suspicions of an inborn error of immunity, and the accurate diagnosis of APECED (autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy) was made by detecting a pathogenic variant in the AIRE gene through new- generation sequencing technologies.
Conclusion: Nowadays, there is access to new genetic tools to establish an early diagnosis of the different inborn errors of immunity; thus, offering timely treatment and a better prognosis.
References
Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet. 1997;17(4):399-403. dio:10.1038/ng1297-399
Bousfiha A, Jeddane L, Ailal F, Al-Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside. J Clin Immunol. 2013;33(6):1078-1087. DOI:10.1007/s10875-013-9901-6
Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol. 2020;40(1):66-81. DOI: 10.1007/s10875-020-00758-x
de Martino L, Capalbo D, Improda N, D’Elia F, Di Mase R, D’Assante R, et al. APECED: a paradigm of complex interactions between genetic background and susceptibility factors. Front Immunol. 2013;4:331. DOI:10.3389/fimmu.2013.00331
Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-eectodermal dystrophy. J Clin Endocrinol Metab. 2006;91:2843-2850. DOI: 10.1210/jc.2005-2611
Betterle C, Greggio NA, Volpato M. Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab. 1998;83(4):1049-1055. DOI: 10.1210/jcem.83.4.4682
Capalbo D, de Martino L, Giardino G, di Mase R, di Donato I, Parenti G, et al. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: insights into genotypephenotype correlation. Int J Endocrinol. 2012;2012:353250. DOI: 10.1155/2012/35325071
Husebye ES, Perheentupa J, Rautemaa R, Kämpe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med. 2009;265(5):514-529. DOI: 10.1111/j.1365-2796.2009.02090.x.73
Ferre EM, Rose SR, Rosenzweig SD, Burbelo PD, Romito KR, Niemela JE, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016;18;1(13):e88782. DOI: 10.1172/jci.insight.88782
Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Horm Metab Res. 1996;28(7):353-356. DOI: 10.1055/s-2007-979814.
Meloni A, Willcox N, Meager A, Atzeni M, Wolff AS, Husebye ES, et al. Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients. J Clin Endocrinol Metab. 2012;97(4):1114-1124. DOI: 10.1210/jc.2011-2461
Fierabracci A, Pellegrino M, Frasca F, Kilic SS, Betterle C. APECED in Turkey: a case report and insights on genetic and phenotypic variability. Clin Immunol. 2018;194:60-66. DOI: 10.1016/j.clim.2018.06.012
Meager A, Visvalingam K, Peterson P, Möll K, Krohn K, Eskelin P, et al. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 2006;3(7):e88782. DOI: 10.1371/journal.pmed.0030289
Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Etzioni A, Franco JL, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40(1):24-64. Doi: 10.1007/s10875-019-00737-x
Costa-Carvalho BT, Grumach AS, Franco JL, Espinosa-Rosales FJ, Leiva LE, King A, et al. Attending to warning signs of primary immunodeficiency diseases across the range of clinical practice. J Clin Immunol. 2014;34(1):10-22. DOI: 10.1007/s10875-013-9954-6
Constantine GM, Lionakis MS. Lessons from primary immunodeficiencies: Autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Immunol Rev. 2019;287(1):103-120. DOI: 10.1111/imr.12714
Kisand K, Peterson P. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. J Clin Immunol. 2015;35(5):463-478. DOI: 10.1007/s10875-015-0176-y
Rodríguez-Santiago B, Armengol L. Tecnologías de secuenciación de nueva generación en el diagnóstico pre- y postnatal. Diagn Prenat. 2012;23(2):56-66 DOI: 10.1016/j.diapre.2012.02.001
Behjati S, Tarpey PS. What is next generation sequencing? Archis Dis Child Educ Pract Ed. 2013;98(6):236-238. DOI:10.1136/archdischild-2013-304340
Conley ME, Casanova JL. Discovery of single-gene inborn errors of immunity by next generation sequencing. Curr Opin Immunol. 2014;30:17-23. DOI: 10.1016/j.coi.2014.05.004
Bucciol G, van Nieuwenhove E, Moens L, Itan Y, Meyts I. Whole exome sequencing in inborn errors of immunity. Curr Opin Allergy Clin Immunol. 2017;17(6):421-430. DOI: 10.1097/aci.0000000000000398
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2021 Revista Alergia México